Selank vs Semax
Selank and Semax are the two most prominent nootropic peptides, both developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. While often mentioned together, they serve different primary research functions: Selank is primarily anxiolytic (anti-anxiety) with cognitive benefits, while Semax is primarily cognitive-enhancing with neuroprotective properties.
Both are approved medications in Russia — Selank for anxiety disorders and Semax for stroke recovery and cognitive enhancement. For research purposes, they represent two distinct approaches to peptide-based neurological modulation.
Similarities
- =Both developed at the Institute of Molecular Genetics, Russian Academy of Sciences
- =Both are approved medications in Russia and several CIS countries
- =Both are administered intranasally in most research protocols
- =Both show neuroprotective properties in published research
- =Both modulate BDNF (Brain-Derived Neurotrophic Factor) expression
- =Both have favorable safety profiles with minimal reported side effects in clinical use
Key Differences
| Aspect | Selank | Semax |
|---|---|---|
| Derived From | Tuftsin (immunomodulatory peptide) + stabilizing sequence | ACTH(4-10) fragment (adrenocorticotropic hormone) + Pro-Gly-Pro |
| Primary Effect | Anxiolytic (anti-anxiety) with secondary nootropic effects | Cognitive enhancement with secondary neuroprotective effects |
| Mechanism | Modulates GABA system, enkephalins, serotonin, dopamine | Modulates BDNF, NGF, dopaminergic and serotonergic systems |
| Key Research Area | Anxiety, stress response, immunomodulation | Cognitive decline, stroke recovery, ADHD, neuroprotection |
| Immunological Effects | Strong immunomodulatory effects — influences cytokine production | Minimal immunological activity |
| Russian Approval | Approved for generalized anxiety disorder | Approved for stroke, cognitive disorders, optic nerve disease |
| Typical Research Form | Intranasal spray (0.15% solution) | Intranasal spray (0.1% or 1% solution) |
Which to Choose for Your Research
Anxiety and stress research
SelankSelank's primary research application is anxiolytic activity. Studies show it modulates GABA-ergic neurotransmission and reduces anxiety-like behavior in animal models without sedation or dependence.
Cognitive enhancement research
SemaxSemax has stronger published evidence for cognitive enhancement, including improved memory consolidation, attention, and learning in both animal and human studies.
Stroke / neuroprotection research
SemaxSemax is approved in Russia specifically for stroke recovery. Published research shows neuroprotective effects and improved outcomes in cerebral ischemia models.
Immune system modulation research
SelankSelank has unique immunomodulatory properties, influencing IL-6, TNF-alpha, and other cytokines. This dual anxiolytic-immunomodulatory profile is unique among peptides.
Combined cognitive + mood research
BothResearchers sometimes study both peptides together — Selank for mood/anxiety modulation and Semax for cognitive enhancement. They act through different primary mechanisms.
The Verdict
Selank and Semax target different aspects of neurological function. Selank is the better-researched option for anxiety, stress, and immunomodulation studies. Semax is stronger for cognitive enhancement, neuroprotection, and stroke recovery research. Both have robust clinical data from Russian medical practice and are available from research vendors as intranasal preparations.
For researchers new to nootropic peptides, the choice depends on the primary research question: anxiety/mood (Selank) vs cognition/neuroprotection (Semax). Both are considered well-tolerated with minimal side effects in published literature.
Frequently Asked Questions
Can Selank and Semax be combined in research?
Yes, researchers sometimes study both peptides concurrently as they act through different primary mechanisms. Selank targets the GABA/enkephalin systems while Semax modulates BDNF and dopaminergic pathways. There is limited published data on the specific combination.
Are Selank and Semax available as nasal sprays?
Both are most commonly available in lyophilized powder form from research vendors, which can be reconstituted for intranasal research protocols. Some vendors sell pre-made nasal spray formulations. Intranasal is the standard research route for both peptides.
Which has more published research?
Both have substantial Russian-language research. Semax has more international publications, partly because of its stroke/neuroprotection applications. Selank's research is more concentrated in anxiety and immunology. Both have human clinical data from Russian medical practice.
Do either cause dependence in research?
Neither Selank nor Semax has shown dependence potential in published studies. This distinguishes them from benzodiazepines (for anxiety) and stimulants (for cognition). Both are considered non-addictive in Russian clinical practice.
Selank
View full compound page with vendor pricing.
Compare 28 products →Semax
View full compound page with vendor pricing.
Compare 17 products →For research reference only. Not medical advice. Not for human consumption. All compounds discussed are research chemicals.